New Delhi, August 2
A registry of hospitalised COVID-19 sufferers throughout the nation is being mooted to gather actual time knowledge to assist enhance remedy outcomes, analyse developments within the development of the pandemic and calibrate response, officers stated.
The ICMR in collaboration with the Health Ministry and the AIIMS is planning to arrange the National Clinical Registry, which can assist researchers and coverage makers perceive effectiveness of investigational therapies, adversarial results happening and generate proof for enhancing the remedy of COVID-19 sufferers.
“The aim is to collect data of the hospitalised COVID-19 patients like clinical and laboratory features, their demographics, comorbidities, treatment outcomes, complications in all age groups among others,” officers stated.
The novel coronavirus, SARS-CoV-2 and the sickness it’s inflicting has so many unknown parameters which might be a barrier to the right understanding and administration of the illness, they stated.
“A systematically collected, comprehensive database covering different regions of the country will enable both researchers and policy makers to generate pertinent hypotheses, to inform crucial understanding of COVID 19, to detect trends in the progression of the pandemic and to accordingly calibrate response to the pandemic,” an official stated.
Fifteen establishments of nationwide reputation together with the Post Graduate Institute of Medical Education & Research (PGIMER) in Chandigarh, AIIMS Delhi, AIIMS Jodhpur, National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru and Armed Force Medical College in Pune will join with the hospitals and medical schools to get them on board.
These 15 establishments could be the registry websites and could be mentoring round 100 COVID-19 hospitals, which might be referred to as satellite tv for pc centres from the place the information could be collected as a part of the train.
The proposal has been despatched for approval to the Central Ethics Committee on Human Research (CECHR) of the ICMR.
“The data will help improve the clinical management protocols as the repository would help us know which drug is working better in which age group, effectiveness of investigational therapies and adverse effects taking place. The idea is to generate evidence for improving the treatment of COVID-19 patients,” one other official stated. PTI